Jayson Bedford
Stock Analyst at Raymond James
(3.91)
# 630
Out of 4,979 analysts
318
Total ratings
57.14%
Success rate
7.54%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $104.71 | +7.92% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $130.41 | +38.03% | 21 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $92.33 | +10.47% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $78.00 | +30.77% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $108.14 | +14.67% | 26 | Jul 24, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $142 → $141 | $132.20 | +6.66% | 29 | Jul 18, 2025 | |
| PODD Insulet | Maintains: Outperform | $328 → $360 | $349.56 | +2.99% | 27 | May 27, 2025 | |
| MASI Masimo | Maintains: Outperform | $204 → $185 | $148.91 | +24.24% | 7 | May 7, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $162 → $164 | $178.13 | -7.93% | 23 | Apr 16, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $560 → $688 | $470.00 | +46.38% | 8 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $191.58 | +40.93% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.04 | -18.95% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $10.90 | -8.26% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $130.18 | +108.17% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.85 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.50 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $80.21 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.09 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $92.99 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $0.44 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $66.54 | +29.25% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.35 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.68 | - | 3 | Jan 2, 2018 |
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $104.71
Upside: +7.92%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $130.41
Upside: +38.03%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $92.33
Upside: +10.47%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $78.00
Upside: +30.77%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $108.14
Upside: +14.67%
Abbott Laboratories
Jul 18, 2025
Maintains: Outperform
Price Target: $142 → $141
Current: $132.20
Upside: +6.66%
Insulet
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $349.56
Upside: +2.99%
Masimo
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $148.91
Upside: +24.24%
Johnson & Johnson
Apr 16, 2025
Maintains: Outperform
Price Target: $162 → $164
Current: $178.13
Upside: -7.93%
Intuitive Surgical
Jan 24, 2025
Maintains: Outperform
Price Target: $560 → $688
Current: $470.00
Upside: +46.38%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $191.58
Upside: +40.93%
Jul 1, 2024
Initiates: Outperform
Price Target: $13
Current: $16.04
Upside: -18.95%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $10.90
Upside: -8.26%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $130.18
Upside: +108.17%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $15.85
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $12.50
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $80.21
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $24.09
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $92.99
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $0.44
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $66.54
Upside: +29.25%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.35
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $15.68
Upside: -